Involvement of insulin-like growth factor-1 in the effect of caloric restriction: Regulation of plasma adiponectin and leptin

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 62, Issue 1, 2007, Pages 27-33

  Yamaza, Haruyoshi ^a   Komatsu, Toshimitsu ^a   To, Kazuo ^a   Toyama, Hiroaki ^a   Chiba, Takuya ^a   Higami, Yoshikazu ^a   Shimokawa, Isao ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; GROWTH HORMONE; INSULIN; LEPTIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C; MESSENGER RNA; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; INSULIN SENSITIVITY; LONGEVITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; SIGNAL TRANSDUCTION; ADENOHYPOPHYSIS; AGING; ANIMAL; BLOOD; DRUG EFFECT; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

MAMMALIA; RATTUS;

ADIPONECTIN; AGING; ANIMALS; BLOOD GLUCOSE; CALORIC RESTRICTION; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; PITUITARY GLAND, ANTERIOR; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34047113944     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/62.1.27     Document Type: Article

References (43)

1. Weindruch R, Walford RL. The Retardation of Aging and Disease by Dietary Restriction. Springfield, IL: Charles C. Thomas; 1988.
2. Masoro EJ. Subfield history: caloric restriction, slowing aging, and extending life. Sci Aging Knowledge Environ. 2003;2003:RE2.
3. Longo VD, Finch CE. Evolutionary medicine: from dwarf model systems to healthy centenarians? Science. 2003;299:1342-1346.
4. Bartke A, Chandrashekar V, Dominici F, et al. Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights. Biogerontology. 2003;4:1-8.
5. Breese CR, Ingram RL, Sonntag WE. Influence of age and long-term dietary restriction on plasma insulin-like growth factor-1 (IGF-1), IGF-1 gene expression, and IGF-1 binding proteins. J Gerontol. 1991;46:B180-B187.
6. Sonntag WE, Lenham JE, Ingram RL. Effects of aging and dietary restriction on tissue protein synthesis: relationship to plasma insulin-like growth factor-1. J Gerontol. 1992;47:B159-B163.
7. Tomita M, Shimokawa I, Higami Y, et al. Modulation by dietary restriction in gene expression related to insulin-like growth factor-1 in rat muscle. Aging (Milano). 2001;13:273-281.
8. Reaven E, Wright D, Mondon CE, Solomon R, Ho H, Reaven GM. Effect of age and diet on insulin secretion and insulin action in the rat. Diabetes. 1983;32:175-180.
9. Kalant N, Stewart J, Kaplan R. Effect of diet restriction on glucose metabolism and insulin responsiveness in aging rats. Mech Ageing Dev. 1988;46:89-104.
10. Masoro EJ, McCarter RJ, Katz MS, McMahan CA. Dietary restriction alters characteristics of glucose fuel use. J Gerontol. 1992;47:B202-B208.
11. Shimokawa I, Higami Y, Utsuyama M, et al. Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model. Am J Pathol. 2002;160:2259-2265.
12. Shimokawa I, Higami Y, Tsuchiya T, et al. Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction. FASEB J. 2003;17:1108-1109.
13. Yamaza H, Komatsu T, Chiba T, et al. A transgenic dwarf rat model as a tool for the study of calorie restriction and aging. Exp Gerontol. 2004;39:269-272.
14. Holzenberger M, Dupont J, Ducos B, et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 2003;421:182-187.
15. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004;53:S143-S151.
16. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia. 2003;46:1594-1603.
17. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947-953.
18. Combs TP, Berg AH, Rajala MW, et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes. 2003;52:268-276.
19. Zhu M, Miura J, Lu LX, et al. Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization. Exp Gerontol. 2004;39:1049-1059.
20. Shimokawa I, Higami Y. A role for leptin in the antiaging action of dietary restriction: a hypothesis. Aging (Milano). 1999;11:380-382.
21. Gazdag AC, Dumke CL, Kahn CR, Cartee GD. Calorie restriction increases insulin-stimulated glucose transport in skeletal muscle from IRS-1 knockout mice. Diabetes. 1999;48:1930-1936.
22. Matsumoto K, Kakidani H, Takahashi A, et al. Growth retardation in rats whose growth hormone gene expression was suppressed by antisense RNA transgene. Mol Reprod Dev. 1993;36:53-58.
23. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-2410.
24. Chapman IM, Hartman ML, Pieper KS, et al. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I. J Clin Endocrinol Metab. 1998;83:2836-2842.
25. Eshet R, Gil-Ad I, Apelboym O, Segev Y, Phillip M, Werner H. Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile rats. J Mol Neurosci. 2004;22:179-188.
26. Cool JC, Dyer JL, Xian CJ, Butler RN, Geier MS, Howarth GS. Pretreatment with insulin-like growth factor-1 partially ameliorates 5-fiuorouracil-induced intestinal mucositis in rats. Growth Horm IGF Res. 2005;15:72-82.
27. Ranke MB. Insulin-like growth factor-1 treatment of growth disorders, diabetes mellitus and insulin resistance. Trends Endocrinol Metab. 2005;16:190-197.
28. Frystyk J. Free insulin-like growth factors-measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res. 2004;14:337-375.
29. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK, Kopchick JJ. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res. 2004;14:309-318.
30. Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. Endocrinology. 2005;146:851-860.
31. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 2001;50:1126-1133.
32. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51:1884-1888.
33. Lam KS, Xu A, Tan KC, Wong LC, Tiu SC, Tarn S. Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. J Clin Endocrinol Metab. 2004;89:5448-5453.
34. Nilsson L, Binart N, Bohlooly YM, et al. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem Biophys Res Comnmn. 2005;331:1120-1126.
35. Peter MA, Winterhalter KH, Boni-Schnetzler M, Froesch ER, Zapf J. Regulation of insulin-like growth factor-1 (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue. Endocrinology. 1993;133:2624-2631.
36. Fischer-Posovszky P, Tornqvist H, Debatin KM, Wabitsch M. Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)/IGF-I receptor autocrine circuit. Endocrinology. 2004;145:1849-1859.
37. Massague J, Czech MP. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem. 1982;257:5038-5045.
38. Zapf J, Schoenle E, Froesch ER. Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem. 1978;87:285-296.
39. Mizuno TM, Bergen H, Funabashi T, et al. Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity. Proc Natl Acad Sci U S A. 1996;93:3434-3438.
40. Boni-Schnetzler M, Hauri C, Zapf J. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats. Diabetologia. 1999;42:160-166.
41. Saladin R, De Vos P, Guerre-Millo M, et al. Transient increase in obese gene expression after food intake or insulin administration. Nature. 1995;377:527-529.
42. Sinha MK, Opentanova I, Ohannesian JP, et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest. 1996;98:1277-1282.
43. Boni-Schnetzler M, Gosteli-Peter MA, Moritz W, Froesch ER, Zapf J. Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I. Biochem Biophys Res Commun. 1996;225:296-301.